Clinical Trial

EC-THP Versus TCbHP in HER2-positive Lymph Node Positive Early Breast Cancer

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
compare the efficacy and safety of TCbHP and EC-THP regimen in HER2-positive breast cancer patients
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-05-31; most recent amendment 2023-06-23.
Status change: Not Yet Recruiting → Recruiting 2023-06-06
Trial Details
NCT Number NCT05883852
Lead Sponsor Fudan University
Conditions HER2 Positive Early Breast Cancer
Enrollment 1,406 participants
Start Date 2023-06-07
Primary Completion 2031-07-01 (estimated)
Study Completion 2031-07-01 (estimated)
Updated on ClinicalTrials.gov 2023-06-27